MICROPORT NEURO (02172) released its annual performance, with a net profit of 184 million yuan, a decrease of 26.2% year-on-year.
Minimally Invasive Brain Science (02172) released its annual results for the year ending December 31, 2025. The group achieved a revenue of 790 million RMB, an increase of 3.8% year-on-year; a net profit of 184 million RMB, a decrease of 26.2% year-on-year; basic earnings per share of 0.32 yuan; and proposed a final dividend of 0.09 Hong Kong dollars per share.
MICROPORT NEURO (02172) announced its financial results for the year ending December 31, 2025. The group achieved a revenue of 790 million RMB, an increase of 3.8% compared to the previous year. The net profit was 184 million RMB, a decrease of 26.2% compared to the previous year. The basic earnings per share were 0.32 yuan. It is proposed to distribute a final dividend of 0.09 Hong Kong dollars per share.
Related Articles
Under Musk's ownership, SpaceX is aiming to conduct the largest IPO in history, with plans to raise up to $75 billion.
US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%
KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.
Under Musk's ownership, SpaceX is aiming to conduct the largest IPO in history, with plans to raise up to $75 billion.
US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%
KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.
